---
title: "Profit C&C: Does not involve the transfer and refinancing business"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/269965978.md"
description: "On December 17th, Profit C&C stated on the interactive platform that the company's stock is currently not a subject security for transfer and financing, and does not involve transfer and financing business"
datetime: "2025-12-17T06:35:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269965978.md)
  - [en](https://longbridge.com/en/news/269965978.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269965978.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/269965978.md) | [繁體中文](https://longbridge.com/zh-HK/news/269965978.md)


# Profit C&C: Does not involve the transfer and refinancing business

On December 17th, Profit C&C (300640.SZ) stated on the interactive platform that the company's stock is currently not a subject security for transfer and financing, and does not involve transfer and financing business

### Related Stocks

- [Profit C&C (300640.CN)](https://longbridge.com/en/quote/300640.CN.md)

## Related News & Research

- [Magontec Sets 12 May Date for 2026 AGM and Opens Proxy Voting](https://longbridge.com/en/news/281463268.md)
- [CATL's controlling shareholder to donate some A-shares](https://longbridge.com/en/news/281197776.md)
- [Zhejiang Supor Earmarks 2 Billion Yuan to Buy Wealth Management Products](https://longbridge.com/en/news/281600548.md)
- [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/en/news/281213207.md)
- [Biocytogen and Sihuan partner to advance new therapeutics for weight loss](https://longbridge.com/en/news/281501537.md)